The risk of secondary malignancies following purine analog therapy of chronic lymphocytic leukemia (CLL) and hairy cell leukemia (HCL).

Publication Type
Journal Article
Year of Publication
1997
Authors
Vena D, Barrett J
Secondary
Proc ASCO.
Pagination
52
Date Published
1997